Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.20
+0.16 (1.23%)
At close: Apr 28, 2026, 4:00 PM EDT
13.04
-0.16 (-1.21%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.56 billion as of April 28, 2026. Its market cap has increased by 122.51% in one year.
Market Cap
1.56B
Enterprise Value
1.05B
1-Year Change
122.51%
Ranking
Category
Stock Price
$13.20
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.56B, an increase of 105.86%. That is a compound annual growth rate of 7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.54B | 47.94% |
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.65B |
| Nanobiotix | 1.61B |
| Rapport Therapeutics | 1.60B |
| Generate Biomedicines | 1.59B |
| Oculis Holding AG | 1.58B |
| Nuvation Bio | 1.57B |
| AtaiBeckley | 1.55B |
| Immatics | 1.54B |